Woodward Diversified Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,393
Closed -$213K 156
2023
Q2
$213K Sell
1,393
-180
-11% -$28.1K 0.16% 129
2023
Q1
$244K Sell
1,573
-40
-2% -$6.28K 0.19% 116
2022
Q4
$249K Sell
1,613
-195
-11% -$28.8K 0.2% 116
2022
Q3
$239K Sell
1,808
-1,161
-39% -$163K 0.2% 111
2022
Q2
$402K Sell
2,969
-795
-21% -$110K 0.31% 84
2022
Q1
$561K Sell
3,764
-4,294
-53% -$635K 0.37% 75
2021
Q4
$1.3M Sell
8,058
-246
-3% -$39.8K 0.77% 34
2021
Q3
$1.38M Sell
8,304
-113
-1% -$19.3K 0.86% 26
2021
Q2
$1.45M Sell
8,417
-1,747
-17% -$289K 0.83% 26
2021
Q1
$1.63M Sell
10,164
-3,981
-28% -$682K 0.96% 23
2020
Q4
$2.38M Buy
+14,145
New +$2.29M 1.54% 12

Other funds holding FBT

Woodward Diversified Capital's FBT Position: Q3 2023 in Review

Woodward Diversified Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2023, closing a stake of 1,393 shares — an estimated $213K sold.

Woodward Diversified Capital first reported a position in FBT in Q4 2020 and held it in 11 quarters. The position peaked at $2.38M in Q4 2020. 242 funds tracked by Wall St. Rank hold FBT as of Q3 2023.

  • Woodward Diversified Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2023 after selling out during the quarter.
  • Woodward Diversified Capital sold 1,393 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2023, an estimated $213K.
  • Woodward Diversified Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and held it in 11 quarters.
  • Woodward Diversified Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.38M in Q4 2020.
  • 242 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2023.

Based on Woodward Diversified Capital's 13F filing for Q3 2023, filed 1 Nov 2023.